Skip to main content

Advertisement

SpringerLink
Log in

6-amide-2-aryl benzoxazole/benzimidazole derivatives as VEFGR-2 inhibitors in two-and three-dimensional QSAR studies: topomer CoMFA and HQSAR

  • Original Paper
  • Published:
Chemical Papers Aims and scope Submit manuscript

Abstract

The vascular endothelial growth factor (VEGF) is the main target of tumor treatment. VEGFR-2 is the main functional receptor of VEGF, which is involved in the regulation of angiogenesis. Based on hologram quantitative structure activity relationships (HQSAR) and topomer comparative molecular field analysis (topomer CoMFA), the contribution of 6-amide-2-aryl benzoxazole/benzimidazole derivatives (VEGFR-2 kinase inhibitors) to these structures was discussed and the corresponding modification strategies were proposed. The most effective HQSAR and topomer CoMFA models are generated by using a training set of 33 compounds. In order to ensure the robustness of the model, the randomization test was used, and 11 compounds were selected as the test set. The results show that the q2 of cross-validation is 0.646/0.659, and the r2 of non-cross-validation is 0.871/0.867, respectively. The data show that both models are reliable. Topomer CoMFA’s steric/electrostatic contour and HQSAR’s atomic contribution map show the structural characteristics controlling its inhibition ability. In addition, molecular docking is also used to study the interaction between these drugs and large proteins, and the ligand pair is connected to the active site of VEGFR-2 kinase, revealing the possible biological active conformation. This study showed that there was a wide interaction between 6-amide-2-aryl benzoxazole/benzimidazole derivatives and Hrg136 and Tyr356 residues of VEGFR-2 kinase active site. Finally, we used ADMET properties and drug-like properties to predict the newly designed molecules, and the results showed that they meet the conditions for becoming drugs and are expected to become potential anti-VEGFR-2 inhibitors. This study can provide a theoretical reference for the synthesis of target products of VEGFR-2 inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3.
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Aarjane M, Aouidate A, Slassi S, Amine A (2020) Synthesis, antibacterial evaluation, in silico ADMET and molecular docking studies of new N-acylhydrazone derivatives from acridone. Arab J Chem 13(7):6236–6245

    Article  CAS  Google Scholar 

  • Agahi F, Juan C, Font G, Juan-García A (2020) In silico methods for metabolomic and toxicity prediction of zearalenone, α-zearalenone and β-zearalenone. J Food Chem Tox 146:111818

    Article  CAS  Google Scholar 

  • Ancuceanu R, Tamba B, Stoicescu CS (2020) Use of qsar global models and molecular docking for developing new inhibitors of c-src tyrosine kinase. Internation J Mole Sci 21(1):199–215

    Google Scholar 

  • Bray F, Mller B (2006) Predicting the future burden of cancer. Nat Rev Cancer 6(1):63–74

    Article  CAS  PubMed  Google Scholar 

  • Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol 13(8):790–801

    Article  PubMed  Google Scholar 

  • Cramer RD (2012) R-group template CoMFA combines benefits of “ad hoc” and topomer alignments using 3D-QSAR for lead optimization. J Comput Aid Mol Des 26(7):805–819

    Article  CAS  Google Scholar 

  • Doddareddy MR, Lee YJ, Yong SC, Choi KI, Koh HY, Pae AN (2004) Hologram quantitative structure activity relationship studies on 5-HT6 antagonists. Bioorgan Med Chem 12(14):3815–3824

    Article  CAS  Google Scholar 

  • Farhood B, Raei B, Malekzadeh R (2019) A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries. Contemp Onc Wsp Onk 23(1):7–15

    Google Scholar 

  • Ferlay J, Shin H-R, Bray F, Forman D, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer 127(12):2893–2917

    Article  CAS  PubMed  Google Scholar 

  • Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438(7070):967–974

    Article  CAS  PubMed  Google Scholar 

  • Gersten O, Wilmoth JR (2002) The cancer transition in Japan since 1951. Demogra Res 7(5):271–306

    Article  Google Scholar 

  • Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Model 20(4):269–276

    Article  CAS  PubMed  Google Scholar 

  • Jain AN (2007) Surflex Dock 2.1: robust performance from ligand energetic modeling ring flexibility and knowledge-based search. J Comput Aid Mol Des 21(5):281–306

    Article  CAS  Google Scholar 

  • Ajay JN (2003) Surflex:? fully automatic flexible molecular docking using a molecular similarity-based search engine. J Med Chem. 46(4):499–511

    Article  Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay JJ, Forman D (2011) Global cancer statistics. J Clin 61(2):69–90

    Google Scholar 

  • Kallab T, Schfer B, Viveiros A (2020) Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study. Z Gastroenterol 58(05):144–156

    Google Scholar 

  • Kumar S, Tiwari M (2015) Topomer-CoMFA-based predictive modelling on 2,3-diaryl-substituted-1,3-thiazolidin-4-ones as non-nucleoside reverse transcriptase inhibitors. Med Chem Res 24(1):245–257

    Article  CAS  Google Scholar 

  • Lee HS, Lee NCO, Kouprina N (2016) Effects of anticancer drugs on chromosome instability and new clinical implications for tumor-suppressing therapies. Cancer Resear 76(4):902–911

    Article  CAS  Google Scholar 

  • Lee WS, Yang H, Chong HJ (2020) Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Exper Mol Med 52(9):1475–1485

    Article  CAS  Google Scholar 

  • Leeson PD, Oprea TI (2011) Chapter 2:Drug-Like Physicochemical Properties. Quant Approach, Drug Des Strat, pp 35–59

    Google Scholar 

  • Li C, Wang P, Zhen Z (2017) 3D-QSAR, Topomer CoMFA, docking analysis, and ADMET prediction of thioether pleuromutilin derivatives as antibacterial agents. Lett Drug Des Discov 14(8):869–879

    Google Scholar 

  • Li X, Kleinstreuer NC, Fourches D (2020) Hierarchical quantitative structure-activity relationship modeling approach for integrating binary, multiclass, and regression models of acute oral systemic toxicity. Chem Resear Toxic 33(2):353–366

    Article  CAS  Google Scholar 

  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1. Advan Drug Del Rev 64:4–17

    Article  Google Scholar 

  • Papetti M, Herman IM (2002) Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol-Cell Physiol 282(5):C947–C970

    Article  CAS  PubMed  Google Scholar 

  • Purcell WP, Singer JA (1967) A brief review and table of semiempirical parameters used in the Hueckel molecular orbital method. J Chem Eng Data 12(2):235–246

    Article  CAS  Google Scholar 

  • Roskoski R (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hemat 62(3):179–213

    Article  Google Scholar 

  • Roy K, Das RN, Ambure P, Aher RB (2016) Be aware of error measures. Further studies on validation of predictive QSAR models. Chemometr Intell Lab 152:18–33

    Article  CAS  Google Scholar 

  • Seal A, Aykkal R, Babu RO, Ghosh MG (2011) Docking study of HIV-1 reverse transcriptase with phytochemicals. Bioinformation 5(10):430–439

    Article  PubMed  PubMed Central  Google Scholar 

  • Shibuya M (2011) Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2(12):1097–1105

    Article  PubMed  PubMed Central  Google Scholar 

  • Tong JB, Bai M, Zhao X (2016) 3D-QSAR and docking studies of HIV-1 protease inhibitors using R-group search and Surflex-dock. Med Chem Res 25(11):2619–2630

    Article  CAS  Google Scholar 

  • Tong JB, Wang Y, Lei S (2019) Comprehensive 3D-QSAR and binding mode of dapy inhibitors using r-group search and molecular docking. J Struct Chem 38(1):25–36

    CAS  Google Scholar 

  • Ugarkar AG, Ambre PK, Coutinho EC, Nandan S, Pissurlenkar RRS (2014) Extracting structural requirements for activity of GPR119 agonists: a hologram quantitative structure activity relationship (HQSAR) study. Can J Chem 92(7):670–676

    Article  CAS  Google Scholar 

  • Waller CL (2004) A comparative qsar study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds. J Chem Inf Model 44(2):758–765

    CAS  Google Scholar 

  • Wang Y, Yu S, Ruan X, Yuan J, Shi J (2015) HQSAR and topomer CoMFA for predicting melanocortin-4 receptor binding affinities of trans-4-(4-chlorophenyl) pyrrolidine-3-carboxamides. Chemometr Intell Lab 146:34–41

    Article  Google Scholar 

  • Wasko MJ, Pellegrene KA, Madura JD (2015) A role for fragment-based drug design in developing novel lead compounds for central nervous system targets. Front Neur 6:197

    Article  Google Scholar 

  • Tong W, David Lowis R, Perkins R, Chen Yu, William J (1998) Evaluation of quantitative structure−activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor. J Chem Inf Model 38(4):669–677

    CAS  Google Scholar 

  • Yadav DK, Khan F, Negi AS (2012) Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity. J Mol Mod 18(6):2513–2525

    Article  CAS  Google Scholar 

  • Yang HB, Luo CF, Sun LX, Li J, Cai YC, Wang Z, Li WH, Liu GX, Tang Y (2019) admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35(6):1067–1069

    Article  CAS  PubMed  Google Scholar 

  • Yuan X, Yang Q, Liu T, Li K, Liu Y, Zhu C, Zhang Z, Li L, Zhang C, Xie M, Lin J, Zhang J, Jin Y (2019) Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase. Eur J Med Chem 179:147–165

    Article  CAS  PubMed  Google Scholar 

  • Zhang Z, Song J, Xiang Y (2014) Topomer CoMFA and virtual screening studies of azaindole class renin inhibitors. Comb Chem High Throughtput Screen 17(5):458–472

    Article  Google Scholar 

  • Zhong Z, Yu J, Virshup DM (2020) Wnts and the hallmarks of cancer. Cancer Metasta Rev 39:625–645

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Funds of China (21475081), the Natural Science Foundation of Shaanxi Province of China (2019JM-237), and the Graduate Innovation Fund of Shaanxi University of Science and Technology.

Author information

Authors and Affiliations

  1. College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi’an, 710021, People’s Republic of China

    Jian-Bo Tong, Yi Feng, Ding Luo & Tian-Hao Wang

  2. Shaanxi Key Laboratory of Chemical Additives for Industry, Shaanxi University of Science and Technology, Xi’an, 710021, People’s Republic of China

    Jian-Bo Tong, Yi Feng, Ding Luo & Tian-Hao Wang

Authors
  1. Jian-Bo Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ding Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tian-Hao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian-Bo Tong.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tong, JB., Feng, Y., Luo, D. et al. 6-amide-2-aryl benzoxazole/benzimidazole derivatives as VEFGR-2 inhibitors in two-and three-dimensional QSAR studies: topomer CoMFA and HQSAR. Chem. Pap. 75, 3551–3562 (2021). https://doi.org/10.1007/s11696-021-01588-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11696-021-01588-w

Keywords

Search

Navigation